DTL
NRIX icon

Dynamic Technology Lab’s Nurix Therapeutics NRIX Stock Holding History

Dynamic Technology Lab’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,754
Closed -$109K – 980
2025
Q3 		$109K Buy
+11,754
New +$122K 0.02% 727
2024
Q4 		– Sell
-23,578
Closed -$530K – 1225
2024
Q3 		$530K Buy
+23,578
New +$534K 0.06% 552
2022
Q4 		– Sell
-15,498
Closed -$202K – 1378
2022
Q3 		$202K Buy
+15,498
New +$245K 0.02% 957
2022
Q1 		– Sell
-7,173
Closed -$208K – 1380
2021
Q4 		$208K Buy
+7,173
New +$217K 0.02% 942

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dynamic Technology Lab's NRIX Position: Q4 2025 in Review

Dynamic Technology Lab sold out of Nurix Therapeutics (NRIX) in Q4 2025, closing a stake of 11,754 shares — an estimated $109K sold.

Dynamic Technology Lab first reported a position in NRIX in Q4 2021 and held it in 4 quarters. The position peaked at $530K in Q3 2024. 182 funds tracked by Wall St. Rank hold NRIX as of Q4 2025.

  • Dynamic Technology Lab reported no remaining Nurix Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 11,754 Nurix Therapeutics shares in Q4 2025, an estimated $109K.
  • Dynamic Technology Lab first reported a position in Nurix Therapeutics in Q4 2021 and held it in 4 quarters.
  • Dynamic Technology Lab's Nurix Therapeutics position peaked at $530K in Q3 2024.
  • 182 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q4 2025.

Based on Dynamic Technology Lab's 13F filing for Q4 2025, filed 13 Feb 2026.